Subclinical hypothyroidism. Understanding is the key to decision making

Area of Science:

• Endocrinology
• Internal Medicine
• Thyroidology

Background:

• Subclinical hypothyroidism involves elevated thyrotropin (TSH) with normal serum thyroxine, often without overt symptoms.
• Autoimmune thyroid disease is the primary cause, with prevalence ranging from 2.5% to 10% in various populations.
• Contrary to previous beliefs, 25% to 50% of patients may experience mild, persistent hypothyroid symptoms.

Purpose of the Study:

• To review the definition, prevalence, clinical manifestations, and treatment of subclinical hypothyroidism.
• To highlight the potential for subtle cardiac defects and cholesterol metabolism disturbances.
• To emphasize the need for individualized treatment strategies.

Main Methods:

• Literature review of subclinical hypothyroidism.
• Analysis of diagnostic criteria (elevated TSH, normal thyroxine).
• Evaluation of clinical findings and treatment outcomes.

Main Results:

• Subclinical hypothyroidism can present with mild symptoms in a significant portion of patients.
• Subtle cardiac abnormalities and mild cholesterol metabolism disturbances are common findings.
• Treatment requires careful individualization of levothyroxine dosage.

Conclusions:

• Subclinical hypothyroidism may have more clinical relevance than previously recognized, particularly in patients with pre-existing heart disease.
• Individualized treatment with levothyroxine is crucial to normalize TSH levels, improve symptoms, and minimize side effects.
• Further research may clarify the long-term impact and optimal management of this condition.